Notch activation inhibits AML growth and survival: a potential therapeutic approach
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Although aberrant Notch activation contributes to leukemogenesis in T cells, its role in acute myelogenous leukemia (AML) remains unclear. Here, we report that human AML samples have robust expression of Notch receptors; however, Notch receptor activation and expression of downstream Notch targets are remarkably low, suggesting that Notch is present but not constitutively activated in human AML. The functional role of these Notch receptors in AML is not known. Induced activation through any of the Notch receptors (Notch1–4), or through the Notch target Hairy/Enhancer of Split 1 (HES1), consistently leads to AML growth arrest and caspase-dependent apoptosis, which are associated with B cell lymphoma 2 (BCL2) loss and enhanced p53/p21 expression. These effects were dependent on the HES1 repressor domain and were rescued through reexpression of BCL2. Importantly, activated Notch1, Notch2, and HES1 all led to inhibited AML growth in vivo, and Notch inhibition via dnMAML enhanced proliferation in vivo, thus revealing the physiological inhibition of AML growth in vivo in response to Notch signaling. As a novel therapeutic approach, we used a Notch agonist peptide that led to significant apoptosis in AML patient samples. In conclusion, we report consistent Notch-mediated growth arrest and apoptosis in human AML, and propose the development of Notch agonists as a potential therapeutic approach in AML.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, Notch signaling functions as a tumor suppressor in the malignancies of myeloid origin, such as acute myelogenous leukemia and chronic myeloid leukemia [138, 139].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [138]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715 · cited 2×
“…independent of which activated receptor was expressed, suggesting that a common downstream target expression had no effect on T-ALL cell line growth, whereas Notch inhibition via expression of dnMAML inhibited the growth of the MOLT4 and SUPT1 T-ALL lines, as expected (Weng et al., 2003, 2004).”
BackgroundResultProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266 · cited 1×
“The production of retroviral supernatant and transduction of each cell line was performed following previously established methods (Pear et al., 1993).”
MethodEllisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,696
Notch1 Expression in Early Lymphopoiesis Influences B versus T Lineage Determination
Pui, J. C., Allman, D., Xu, L., DeRocco, S., Karnell, F. G., Bakkour, S., Lee, J. Y., Kadesch, T., Hardy, R. R., Aster, J. C., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80105-3 · Cited by 949
Tibes, R., Qiu, Y., Lu, Y., Hennessy, B., Andreeff, M., Mills, G. B., & Kornblau, S. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0334 · Cited by 718 · cited 1×
“We probed a validated reversephase protein lysate array (RPPA) containing duplicate dilutions of total cell lysates from 560 AML patient samples, 10 normal CD34-selected controls, and 21 normal peripheral blood mononuclear cell controls (Tibes et al., 2006; Kornblau and Coombes, 2011).”
MethodSelf-citationPucci, B., Kasten, M., & Giordano, A. (2000) · Neoplasia · doi:10.1038/sj.neo.7900101 · Cited by 652
Saito, T., Chiba, S., Ichikawa, M., Kunisato, A., Asai, T., Shimizu, K., Yamaguchi, T., Yamamoto, G., Seo, S., Kumano, K., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00111-0 · Cited by 561
Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
Harrison, H., Farnie, G., Howell, S. J., Rock, R. E., Stylianou, S., Brennan, K. R., Bundred, N. J., & Clarke, R. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1681 · Cited by 543 · cited 1×
“Interestingly, AML and normal CD34+ cells expressed similar levels of Notch receptors 1–3, but AML samples expressed significantly higher Notch4, the Notch receptor classically associated with vascular endothelium (Wu et al., 2005) and breast cancer (Harrison et al., 2010).”
REGULATION OF LYMPHOID DEVELOPMENT, DIFFERENTIATION, AND FUNCTION BY THE NOTCH PATHWAY
Maillard, I., Fang, T., & Pear, W. S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115747 · Cited by 439 · cited 1×
“In hematopoietic stem cells, Notch signaling can promote self-renewal, induce growth arrest and apoptosis, and induce commitment to the T cell lineage (Carlesso et al., 1999; Ohishi et al., 2002; Maillard et al., 2005; Yu et al., 2006; Chadwick et al., 2007).”
BackgroundA novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Klinakis, A., Lobry, C., Abdel-Wahab, O., Oh, P., Haeno, H., Buonamici, S., van De Walle, I., Cathelin, S., Trimarchi, T., Araldi, E., et al. (2011) · Nature · doi:10.1038/nature09999 · Cited by 382 · cited 1×
“Mutations have also been found in NOTCH2, MAML1, Nicastrin, and APH1A in patients with chronic myelomonoblastic leukemia (CMML), a myeloproliferative leukemia (Klinakis et al., 2011).”
BackgroundNotch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth
Fan, X., Mikolaenko, I., Elhassan, I., Ni, X., Wang, Y., Ball, D., Brat, D. J., Perry, A., & Eberhart, C. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1446 · Cited by 382 · cited 1×
“…may be a consequence of myeloid development (Jönsson et al., 2001), and may suggest alternate Notch ligand selectivity (Hicks et al., 2000) or differential consequences of Notch1 and Notch2 signaling, as has been reported to have antagonistic effects in embryonal brain tumors (Fan et al., 2004).”
BackgroundFringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2
Hicks, C., Johnston, S. H., diSibio, G., Collazo, A., Vogt, T. F., & Weinmaster, G. (2000) · Nature Cell Biology · doi:10.1038/35019553 · Cited by 373 · cited 2×
“…in Notch receptor expression may be a consequence of myeloid development (Jönsson et al., 2001), and may suggest alternate Notch ligand selectivity (Hicks et al., 2000) or differential consequences of Notch1 and Notch2 signaling, as has been reported to have antagonistic effects in embryonal brain…”
BackgroundGrowth Suppression of Pre-T Acute Lymphoblastic Leukemia Cells by Inhibition of Notch Signaling
Weng, A. P., Nam, Y., Wolfe, M. S., Pear, W. S., Griffin, J. D., Blacklow, S. C., & Aster, J. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.655-664.2003 · Cited by 369
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
Verhaak, R. G. W., Wouters, B. J., Erpelinck, C. A. J., Abbas, S., Beverloo, H. B., Lugthart, S., Lowenberg, B., Delwel, R., & Valk, P. J. M. (2009) · Haematologica · doi:10.3324/haematol.13299 · Cited by 359
Notch and cancer: a double-edged sword
Koch, U., & Radtke, F. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7164-1 · Cited by 333
Canonical Notch Signaling Is Dispensable for the Maintenance of Adult Hematopoietic Stem Cells
Maillard, I., Koch, U., Dumortier, A., Shestova, O., Xu, L., Sai, H., Pross, S. E., Aster, J. C., Bhandoola, A., Radtke, F., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.02.011 · Cited by 317
Li, L., Milner, L. A., Deng, Y., Iwata, M., Banta, A., Graf, L., Marcovina, S., Friedman, C., Trask, B. J., Hood, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80457-4 · Cited by 269
Aster, J. C., Pear, W. S., & Blacklow, S. C. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154300 · Cited by 266 · cited 2×
“Accumulating evidence demonstrates the importance of altered Notch signaling in the growth, differentiation, and apoptosis of human hematopoietic malignancies (Zweidler-McKay and Pear, 2004; Aster et al., 2008; Jundt et al., 2008; Zweidler-McKay, 2008).”
BackgroundAlcalay, M., Meani, N., Gelmetti, V., Fantozzi, A., Fagioli, M., Orleth, A., Riganelli, D., Sebastiani, C., Cappelli, E., Casciari, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17595 · Cited by 249 · cited 2×
“1 D), although median cleaved Notch1/2 was highest in acute promyelocytic leukemia (FAB M3), consistent with a prior publication that found Notch signaling increased in AML cells expressing promyelocytic leukemia-retinoic acid receptor (Alcalay et al., 2003).”
BackgroundCarlesso, N., Aster, J. C., Sklar, J., & Scadden, D. T. (1999) · Blood · doi:10.1182/blood.v93.3.838 · Cited by 245
Negative regulation of bcl-2 expression by p53 in hematopoietic cells
Wu, Y.-L., Mehew, J. W., Heckman, C. A., Arcinas, M., & Boxer, L. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204067 · Cited by 221 · cited 1×
“Furthermore, p53 has been shown to repress BCL2 at the transcriptional level though binding the proximal BCL2 promoter region in hematopoietic cells (Wu et al., 2001).”
BackgroundMiller, C. P., Ban, K., Dujka, M. E., McConkey, D. J., Munsell, M., Palladino, M., & Chandra, J. (2007) · Blood · doi:10.1182/blood-2006-03-013128 · Cited by 204 · cited 1×
“In conflicting studies, Notch signaling in myeloid precursors has been shown to promote self-renewal, induce/inhibit differentiation to monocytes, or induce apoptosis (Li et al., 1998; Carlesso et al., 1999; Masuya et al., 2002; Schroeder et al., 2003; Sarmento et al., 2005).”
BackgroundWouters, B. J., Jordà, M. A., Keeshan, K., Louwers, I., Erpelinck-Verschueren, C. A. J., Tielemans, D., Langerak, A. W., He, Y., Yashiro-Ohtani, Y., Zhang, P., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073486 · Cited by 199 · cited 4×
“The most commonly described Notch downstream target is the basic helix–loop–helix transcription factor Hairy/Enhancer of Split 1 (HES1).”
BackgroundInfluentialZweidler-McKay, P. A., He, Y., Xu, L., Rodriguez, C. G., Karnell, F. G., Carpenter, A. C., Aster, J. C., Allman, D., & Pear, W. S. (2005) · Blood · doi:10.1182/blood-2005-01-0355 · Cited by 193
Self-citationDel Giudice, I., Rossi, D., Chiaretti, S., Marinelli, M., Tavolaro, S., Gabrielli, S., Laurenti, L., Marasca, R., Rasi, S., Fangazio, M., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.060129 · Cited by 191 · cited 7×
“Importantly, the Notch target genes HES1 and Deltex1 (Fig.”
BackgroundInfluentialNotch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation
Sarmento, L. M., Huang, H., Limon, A., Gordon, W., Fernandes, J., Tavares, M. J., Miele, L., Cardoso, A. A., Classon, M., & Carlesso, N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050559 · Cited by 191 · cited 3×
“Others have observed that co-culture with Notch ligand-expressing cells does not affect proliferation of an AML cell line, but alters G1–S transition and inhibits mitogen-induced differentiation (Carlesso et al., 1999; Sarmento et al., 2005).”
BackgroundDelta-1 enhances marrow and thymus repopulating ability of human CD34+CD38– cord blood cells
Ohishi, K., Varnum-Finney, B., & Bernstein, I. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216167 · Cited by 173 · cited 1×
“In hematopoietic stem cells, Notch signaling can promote self-renewal, induce growth arrest and apoptosis, and induce commitment to the T cell lineage (Carlesso et al., 1999; Ohishi et al., 2002; Maillard et al., 2005; Yu et al., 2006; Chadwick et al., 2007).”
BackgroundDefective Notch activation in microenvironment leads to myeloproliferative disease
Kim, Y.-W., Koo, B.-K., Jeong, H.-W., Yoon, M.-J., Song, R., Shin, J., Jeong, D.-C., Kim, S.-H., & Kong, Y.-Y. (2008) · Blood · doi:10.1182/blood-2008-03-148999 · Cited by 166 · cited 2×
“…abnormalities (Maillard et al., 2008), inhibition of Notch ligands through defective fucosylation (Zhou et al., 2008) or impaired endocytosis (Kim et al., 2008), or inhibition of Notch receptor processing in hematopoietic progenitors (Yoda et al., 2011) led to myeloproliferative disease in…”
BackgroundHES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding
Yu, X., Alder, J. K., Chun, J. H., Friedman, A. D., Heimfeld, S., Cheng, L., & Civin, C. I. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0598 · Cited by 116 · cited 1×
“In hematopoietic stem cells, Notch signaling can promote self-renewal, induce growth arrest and apoptosis, and induce commitment to the T cell lineage (Carlesso et al., 1999; Ohishi et al., 2002; Maillard et al., 2005; Yu et al., 2006; Chadwick et al., 2007).”
BackgroundTopography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies Revisited
Jerez, A., Gondek, L. P., Jankowska, A. M., Makishima, H., Przychodzen, B., Tiu, R. V., O'Keefe, C. L., Mohamedali, A. M., Batista, D., Sekeres, M. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1824 · Cited by 110 · cited 2×
“3 to be frequently lost in interstitial deletions of 5q (Jerez et al., 2012).”
BackgroundNotch Signaling Induces Multilineage Myeloid Differentiation and Up-Regulates PU.1 Expression
Schroeder, T., Kohlhof, H., Rieber, N., & Just, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5538 · Cited by 109 · cited 1×
“In conflicting studies, Notch signaling in myeloid precursors has been shown to promote self-renewal, induce/inhibit differentiation to monocytes, or induce apoptosis (Li et al., 1998; Carlesso et al., 1999; Masuya et al., 2002; Schroeder et al., 2003; Sarmento et al., 2005).”
BackgroundExpression of Notchl and Jaggedl Proteins in Acute Myeloid Leukemia Cells
Tohda, S., & Nara, N. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109064603 · Cited by 108 · cited 2×
“Although the presence of Notch1 expression in human AML cells has been previously reported (Tohda and Nara, 2001; Chiaramonte et al., 2005; Yin et al., 2009), the comparative expression of all four Notch receptors has not yet Table 1.”
BackgroundCordle, J., RedfieldZ, C., Stacey, M., van der Merwe, P. A., Willis, A. C., Champion, B. R., Hambleton, S., & Handford, P. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708424200 · Cited by 106
A new genetic lesion in B‐CLL: a NOTCH1 PEST domain mutation
Ianni, M. D., Baldoni, S., Rosati, E., Ciurnelli, R., Cavalli, L., Martelli, M. F., Marconi, P., Screpanti, I., & Falzetti, F. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07816.x · Cited by 104
Figueroa, M. E., Wouters, B. J., Skrabanek, L., Glass, J., Li, Y., Erpelinck-Verschueren, C. A. J., Langerak, A. W., Löwenberg, B., Fazzari, M., Greally, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172387 · Cited by 91
Self-citationNakahara, F., Sakata‐Yanagimoto, M., Komeno, Y., Kato, N., Uchida, T., Haraguchi, K., Kumano, K., Harada, Y., Harada, H., Kitaura, J., et al. (2009) · Blood · doi:10.1182/blood-2009-05-222836 · Cited by 82
Molecular Determinants of NOTCH4 Transcription in Vascular Endothelium
Wu, J., Iwata, F., Grass, J. A., Osborne, C. S., Elnitski, L., Fraser, P., Ohneda, O., Yamamoto, M., & Bresnick, E. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1458-1474.2005 · Cited by 72 · cited 2×
“Interestingly, AML and normal CD34+ cells expressed similar levels of Notch receptors 1–3, but AML samples expressed significantly higher Notch4, the Notch receptor classically associated with vascular endothelium (Wu et al., 2005) and breast cancer (Harrison et al.”
BackgroundNotch-dependent control of myelopoiesis is regulated by fucosylation
Zhou, L., Li, L. W., Yan, Q., Petryniak, B., Man, Y., Su, C., Shim, J., Chervin, S., & Lowe, J. B. (2008) · Blood · doi:10.1182/blood-2007-11-115204 · Cited by 71 · cited 2×
“…studies using dnMAML have not reported myeloid abnormalities (Maillard et al., 2008), inhibition of Notch ligands through defective fucosylation (Zhou et al., 2008) or impaired endocytosis (Kim et al., 2008), or inhibition of Notch receptor processing in hematopoietic progenitors (Yoda et al.,…”
BackgroundA wide role for NOTCH1 signaling in acute leukemia
Chiaramonte, R., Basile, A., Tassi, E., Calzavara, E., Cecchinato, V., Rossi, V., Biondi, A., & Comi, P. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.022 · Cited by 70
Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias
Palomero, T., McKenna, K., O’Neil, J., Galinsky, I. A., Stone, R. M., Suzukawa, K., Stiakaki, E., Kalmanti, M., Fox, E. A., Caligiuri, M. A., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404409 · Cited by 64
Notch Signaling in Leukemias and Lymphomas
Jundt, F., Schwarzer, R., & Dörken, B. (2008) · Current Molecular Medicine · doi:10.2174/156652408783565540 · Cited by 57 · cited 1×
“Accumulating evidence demonstrates the importance of altered Notch signaling in the growth, differentiation, and apoptosis of human hematopoietic malignancies (Zweidler-McKay and Pear, 2004; Aster et al., 2008; Jundt et al., 2008; Zweidler-McKay, 2008).”
BackgroundDual functions of cell-autonomous and non–cell-autonomous ADAM10 activity in granulopoiesis
Yoda, M., Kimura, T., Tohmonda, T., Uchikawa, S., Koba, T., Takito, J., Morioka, H., Matsumoto, M., Link, D. C., Chiba, K., et al. (2011) · Blood · doi:10.1182/blood-2011-06-357210 · Cited by 55
Jönsson, J.-I., Xiang, Z., Pettersson, M., Lardelli, M., & Nilsson, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3240::aid-immu3240>3.0.co;2-e · Cited by 53 · cited 2×
“This difference in Notch receptor expression may be a consequence of myeloid development (Jönsson et al., 2001), and may suggest alternate Notch ligand selectivity (Hicks et al.”
BackgroundZweidler‐McKay, P. A., & Pear, W. S. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.012 · Cited by 49
Self-citationTohda, S., Kogoshi, H., Murakami, N., Sakano, S., & Nara, N. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.01.010 · Cited by 48 · cited 1×
“This group has also provided some information on the effects of Notch signaling on AML cells, where exposure of AML patient samples to plate-bound Notch ligand led to a full range of responses, from proliferation to growth arrest, which varied by sample (Tohda et al., 2005).”
BackgroundNotch Signaling Induces Apoptosis in Primary Human CD34+ Hematopoietic Progenitor Cells
Chadwick, N., Nostro, M. C., Baron, M., Mottram, R., Brady, G., & Buckle, A. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0303 · Cited by 45 · cited 1×
“In hematopoietic stem cells, Notch signaling can promote self-renewal, induce growth arrest and apoptosis, and induce commitment to the T cell lineage (Carlesso et al., 1999; Ohishi et al., 2002; Maillard et al., 2005; Yu et al., 2006; Chadwick et al., 2007).”
BackgroundKornblau, S. M., & Coombes, K. R. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-286-1_10 · Cited by 45 · cited 1×
“We probed a validated reversephase protein lysate array (RPPA) containing duplicate dilutions of total cell lysates from 560 AML patient samples, 10 normal CD34-selected controls, and 21 normal peripheral blood mononuclear cell controls (Tibes et al., 2006; Kornblau and Coombes, 2011).”
MethodSelf-citationNemoto, N., Suzukawa, K., Shimizu, S., Shinagawa, A., Takei, N., Taki, T., Hayashi, Y., Kojima, H., Kawakami, Y., & Nagasawa, T. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20467 · Cited by 43 · cited 1×
“Furthermore, Nemoto et al. (2007) reported a Notch-inhibiting MLL–MAML2 translocation in a case of secondary AML.”
BackgroundThe Soluble Notch Ligand, Jagged-1, Inhibits Proliferation of CD34+ Macrophage Progenitors
Masuya, M., Katayama, N., Hoshino, N., Nishikawa, H., Sakano, S., Araki, H., Mitani, H., Suzuki, H., Miyashita, H., Kobayashi, K., et al. (2002) · International Journal of Hematology · doi:10.1007/bf02982040 · Cited by 40 · cited 1×
“In conflicting studies, Notch signaling in myeloid precursors has been shown to promote self-renewal, induce/inhibit differentiation to monocytes, or induce apoptosis (Li et al., 1998; Carlesso et al., 1999; Masuya et al., 2002; Schroeder et al., 2003; Sarmento et al., 2005).”
BackgroundNotch signaling in pediatric malignancies
Zweidler‐McKay, P. A. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0071-2 · Cited by 38 · cited 1×
“Accumulating evidence demonstrates the importance of altered Notch signaling in the growth, differentiation, and apoptosis of human hematopoietic malignancies (Zweidler-McKay and Pear, 2004; Aster et al., 2008; Jundt et al., 2008; Zweidler-McKay, 2008).”
BackgroundSelf-citationCharacterization of tissue specific expression of Notch-1 in human tissues
Baldi, A. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.01.005 · Cited by 37 · cited 1×
“Activation of the Notch pathway has varied effects on proliferation, differentiation, and survival, which are highly cell type specific, though these cell-specific mechanisms have not been elucidated in most systems (Baldi et al., 2004).”
BackgroundNotch3, another Notch in T cell development
Bellavia, D., Campese, A. F., Vacca, A., Gulino, A., & Screpanti, I. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00007-1 · Cited by 36 · cited 2×
“1, A and B; Bellavia et al., 2003; Saito et al., 2003).”
BackgroundNotch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562
Yin, D., Fan, F.-Y., Hu, X., Hou, L., Zhang, X., Liu, L., Liang, Y., & Han, H. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.06.023 · Cited by 34 · cited 3×
“Although the presence of Notch1 expression in human AML cells has been previously reported (Tohda and Nara, 2001; Chiaramonte et al., 2005; Yin et al., 2009), the comparative expression of all four Notch receptors has not yet Table 1.”
BackgroundCharacterization of tissue specific expression of Notch‐1 in human tissues
Baldi, A., Falco, M. D., Luca, L. D., et al. (2004) · Biology of the Cell · doi:10.1111/j.1768-322x.2004.tb01418.x · Cited by 31
Henning, K., Heering, J., Schwanbeck, R., Schroeder, T., Helmbold, H., Schäfer, H., Deppert, W., Kim, E. L., & Just, U. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402277 · Cited by 26
Notch induces cell cycle arrest and apoptosis in human erythroleukaemic TF-1 cells
Chadwick, N., Fennessy, C., Nostro, M. C., Baron, M., Brady, G., & Buckle, A. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.06.003 · Cited by 21 · cited 1×
“In contrast, Chadwick et al. (2008) show that expression of activated Notch1 in TF-1 AML cells leads to growth arrest and apoptosis.”
Background
Cited by
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Clara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
Kode, A., Manavalan, J. S., Mosialou, I., Bhagat, G., Rathinam, C. V., Luo, N., Khiabanian, H., Lee, A., Murty, V. V., Friedman, R., et al. (2014) · Nature · doi:10.1038/nature12883 · Cited by 532
Therapeutic modulation of Notch signalling — are we there yet?
Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 457
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 374
Metadata
- Authors
- Kannan, S., Sutphin, R. M., Hall, M. G., Golfman, L. S., Fang, W., Nolo, R. M., Akers, L. J., Hammitt, R. A., McMurray, J. S., Kornblau, S. M., Melnick, A. M., Figueroa, M. E., & Zweidler-McKay, P. A.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Department of Pediatric Hematology/Oncology, M.D. Anderson Cancer Center Orlando, Orlando, FL 32806 4
- Cook Children's Medical Center (US)
- Sigma Genosys (United States) (US)
- Weill Cornell Medicine (US)
- Department of Pathology, University of Michigan Health System, Ann Arbor, MI 48109 8
- Division of Pediatrics 1 , 2 , and 3
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-01-28
- Volume
- 210
- Issue
- 2
- Pages
- 321-337
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3570106
- OpenAlex
- W2113096952
- Cited by
- 152
- References
- 59
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 16 · 2021: 8 · 2020: 8 · 2019: 12 · 2018: 12 · 2017: 8 · 2016: 15 · 2015: 18 · 2014: 20 · 2013: 10
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA138816, P30CA016672)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- Notch signaling, acute myeloid leukemia, Notch1, Notch2, Notch3, Notch4, Hes1, apoptosis, Bcl-2, therapeutic target
- MeSH terms
- Transcription Factor HES-1, Adolescent, Animals, Cell Survival, Child, DNA-Binding Proteins, Humans, Infant, Mutation, RNA, Messenger, RNA, Neoplasm, Transcription Factors, Signal Transduction, Leukemia, Myeloid, Acute, Gene Expression, Tumor Suppressor Protein p53, Mice, SCID, Mice, Inbred NOD, Apoptosis, Mice, Knockout, Homeodomain Proteins, Proto-Oncogene Proteins c-bcl-2, Cell Line, Tumor, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.